- Home
- AM vs LEGN Comparison
AM vs LEGN Comparison
Compare AM & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AM
- LEGN
- Stock Information
- Founded
- AM 2013
- LEGN 2014
- Country
- AM United States
- LEGN United States
- Employees
- AM N/A
- LEGN N/A
- Industry
- AM Natural Gas Distribution
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- AM Utilities
- LEGN Health Care
- Exchange
- AM Nasdaq
- LEGN Nasdaq
- Market Cap
- AM 8.5B
- LEGN 7.0B
- IPO Year
- AM 2014
- LEGN 2020
- Fundamental
- Price
- AM $18.86
- LEGN $27.69
- Analyst Decision
- AM Hold
- LEGN Strong Buy
- Analyst Count
- AM 2
- LEGN 13
- Target Price
- AM $16.50
- LEGN $75.67
- AVG Volume (30 Days)
- AM 2.7M
- LEGN 1.5M
- Earning Date
- AM 04-30-2025
- LEGN 05-13-2025
- Dividend Yield
- AM 4.78%
- LEGN N/A
- EPS Growth
- AM 8.49
- LEGN N/A
- EPS
- AM 0.87
- LEGN N/A
- Revenue
- AM $1,188,943,000.00
- LEGN $728,303,000.00
- Revenue This Year
- AM $0.69
- LEGN $65.96
- Revenue Next Year
- AM $2.45
- LEGN $52.55
- P/E Ratio
- AM $21.41
- LEGN N/A
- Revenue Growth
- AM 5.03
- LEGN 112.46
- 52 Week Low
- AM $13.12
- LEGN $29.27
- 52 Week High
- AM $18.49
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- AM 71.77
- LEGN 29.04
- Support Level
- AM $17.28
- LEGN $30.25
- Resistance Level
- AM $18.60
- LEGN $33.30
- Average True Range (ATR)
- AM 0.41
- LEGN 1.78
- MACD
- AM 0.18
- LEGN -0.53
- Stochastic Oscillator
- AM 99.05
- LEGN 3.10
About AM Antero Midstream Corporation
Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin located in West Virginia and Ohio. The company has two operating segments; the Gathering and Processing segment includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio and the Water Handling segment includes two independent systems that deliver water from sources including the Ohio River, local reservoirs and several regional waterways. It derives a majority of its revenue from the Gathering and Processing segment.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.